[go: up one dir, main page]
Skip to main content
SpringerLink
Log in

A Systematic Approach to Systemic Contact Dermatitis and Symmetric Drug-Related Intertriginous and Flexural Exanthema (SDRIFE)

A Closer Look at These Conditions and an Approach to Intertriginous Eruptions

  • Review Article
  • Systematic Approach to Systemic Contact Dermatitis and SDRIFE
  • Published:
American Journal of Clinical Dermatology Aims and scope Submit manuscript

Abstract

Systemic contact dermatitis is a condition that occurs when an individual sensitized to a contact allergen is exposed to that same allergen or a cross-reacting molecule through a systemic route. Systemic exposure to allergens can include transcutaneous, transmucosal, oral, intravenous, intramuscular, and inhalational routes. Baboon syndrome is perhaps the most recognizable form of systemic contact dermatitis, presenting with diffuse, well demarcated erythema of the buttocks, upper inner thighs, and axillae. Other forms of systemic contact dermatitis include dermatitis at sites of previous exposure to the allergen such as at a previous site of dermatitis or at sites of previous positive patch tests, dyshidrotic hand eczema, flexural dermatitis, exanthematous rash, erythroderma, and vasculitis-like lesions.

The most common causes of systemic contact dermatitis consist of three groups of allergens: (i) metals including mercury, nickel, and gold; (ii) medications including aminoglycoside antibacterials, corticosteroids, and aminophylline; and (iii) plants and herbal products including the Compositae and Anacardiaceae plant families and Balsam of Peru.

Baboon syndrome caused by systemic medications without a known history of previous cutaneous sensitization in the patient has been termed drug-related baboon syndrome (DRBS) or symmetric drug-related intertriginous and flexural exanthema (SDRIFE). Criteria for SDRIFE include exposure to systemic drug at first or repeated dose, erythema of the gluteal/perianal area and/or V-shaped erythema of the inguinal area, involvement of at least one other intertriginous localization, symmetry of affected areas, and absence of systemic toxicity. The most common causes are aminopenicillins, β-lactam antibacterials, and certain chemotherapeutic agents, though the list of etiologic agents continues to grow. Baboon syndrome and SDRIFE should be strongly considered in a patient presenting with a symmetric intertriginous eruption involving multiple body folds. With the knowledge of the most frequent causes of these conditions, a detailed history and review of exposures will guide the clinician in the search for the most likely etiologic agent.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Nielsen NH, Linneberg A, Menne T, et al. Allergic contact sensitization in an adult Danish population: two cross-sectional surveys eight years apart (the Copenhagen Allergy Study). Acta Derm Venereol 2001 Jan-Feb; 81 (1): 31–4

  2. Hausermann P, Harr T, Bircher AJ. Baboon syndrome resulting from systemic drugs: is there strife between SDRIFE and allergic contact dermatitis syndrome? Contact Dermatitis 2004 Nov-Dec; 51 (5-6): 297–310

  3. Veien NK, Menne T. Systemic contact dermatitis. In: Frosch PJ, Menne T, Lepoittevin JP, editors. Contact dermatitis. 4th ed. Berlin: Springer, 2006: 295–305

    Chapter  Google Scholar 

  4. Menne T, Veien NK, Maibach HL. Systemic contact dermatitis. Am J Contact Dermatitis 1994; 5: 1–12

    Google Scholar 

  5. Jacob SE, Zapolanski T. Systemic contact dermatitis. Dermatitis 2008 Jan-Feb; 19 (1): 9–15

  6. Shelley WB, Crissey JT. Thomas Bateman. In: Shelley WB, Crissey JT, editors. Classics in clinical dermatology. Springfield (IL): Charles C. Thomas, 1970: 22

    Google Scholar 

  7. Nakayama H, Niki F, Shono M, et al. Mercury exanthema. Contact Dermatitis 1983; 9: 411–7

    Article  PubMed  CAS  Google Scholar 

  8. Andersen KE, Hjorth N, Menne T. The baboon syndrome: systemicallyinduced allergic contact dermatitis. Contact Dermatitis 1984; 10: 97–100

    Article  PubMed  CAS  Google Scholar 

  9. Torchia D, Capretti C, Pizzo B, et al. Patch test triggering recurrence of distant dermatitis: the flare-up phenomenon. CMAJ 2008 Aug 12; 179 (4): 341

  10. Moreno-Ramírez D, García-Bravo B, Pichardo AR, et al. Baboon syndrome in childhood: easy to avoid, easy to diagnose, but the problem continues. Pediatr Dermatol 2004 May-Jun; 21 (3): 250–3

  11. Ozkaya E, Mirzoyeva L, Otkur B. Mercury-induced systemic allergic dermatitis caused by ‘white precipitate’ in a skin lightening cream. Contact Dermatitis 2009; 60: 61–3

    Article  PubMed  Google Scholar 

  12. Dou X, Liu LL, Zhu XJ. Nickel-elicited systemic contact dermatitis. Contact Dermatitis 2003 Mar; 48 (3): 126–9

  13. Nielsen GD, Jepsen LV, Jorgensen PJ. Nickel-sensitive patients with vesicular hand eczema: oral challenge with a diet naturally high in nickel. Br J Dermatol 1990 Mar; 122 (3): 299–308

    Google Scholar 

  14. Pigatto PD, Guzzi G. Systemic contact dermatitis from nickel associated with orthodontic appliances. Contact Dermatitis 2004 Feb; 50 (2): 100–1

  15. Raison-Peyron N, Guillard O, Khalil Z, et al. Nickel-elicited systemic contact dermatitis from a peripheral intravenous catheter. Contact Dermatitis 2005 Oct; 53 (4): 222–5

    Google Scholar 

  16. Raison-Peyron N, Kluger N, Guillard O, et al. A new case of systemic contact eczema to nickel in a peripheral venous catheter. Ann Dermatol Venereol 2008 Nov; 135 (11): 769–72

    Google Scholar 

  17. Nosbaum A, Rival-Tringali AL, Barth X, et al. Nickel-induced systemic allergic dermatitis from a sacral neurostimulator. Contact Dermatitis 2008 Nov; 59 (5): 319–20

    Google Scholar 

  18. Gimenez-Arnau A, Riambau V, Serra-Baldrich E. Metal-induced generalized pruriginous dermatitis and endovascular surgery. Contact Dermatitis 2000 Jul; 43 (1): 35–40

  19. Lofgren SM, Warshaw EM. Dyshidrosis: epidemiology, clinical characteristics, and therapy. Dermatitis 2006 Dec; 17 (4): 165–81

  20. Veien NK, Hattel T, Justesen O, et al. Dietary treatment of nickel dermatitis. Acta Derm Venereol 1985; 65 (2): 138–42

    PubMed  CAS  Google Scholar 

  21. Veien NK, Hattel T, Laurberg G. Low nickel diet: an open, prospective trial. J Am Acad Dermatol 1993 Dec; 29 (6): 1002–7

  22. Guin JD, Phillips D. Erythroderma from systemic contact dermatitis: a complication of systemic gentamicin in a patient with contact allergy to neomycin. Cutis 1989 Jun; 43 (6): 564–7

    Google Scholar 

  23. Quirce S, Alvarez MJ, Olaguibel JM, et al. Systemic contact dermatitis from oral prednisone. Contact Dermatitis 1994 Jan; 30 (1): 53–4

    Google Scholar 

  24. Chew AL, Maibach HI. Multiple corticosteroid orally elicited allergic contact dermatitis in a patient with multiple topical corticosteroid allergic contact dermatitis. Cutis 2000 May; 65 (5): 307–11

    Google Scholar 

  25. Poon E, Fewings JM. Generalized eczematous reaction to budesonide in a nasal spray with cross-reactivity to triamcinolone. Australas J Dermatol 2001 Feb; 42 (1): 36–7

    Google Scholar 

  26. Nucera E, Buonomo A, Pollastrini E, et al. A case of cutaneous delayed-type allergy to oral dexamethasone and to betamethasone. Dermatology 2002; 204 (3): 248–50

    Article  PubMed  Google Scholar 

  27. Walker SL, Ferguson JE. Systemic allergic contact dermatitis due to ethylenediamine following administration of oral aminophylline. Br J Dermatol 2004 Mar; 150 (3): 594

    Google Scholar 

  28. Isaksson M, Ljunggren B. Systemic contact dermatitis from ethylenediamine in an aminophylline preparation presenting as the baboon syndrome. Acta Derm Venereol 2003; 83 (1): 69–70

    Article  PubMed  CAS  Google Scholar 

  29. De Castro Martinez FJ, Ruiz FJ, Tornero P, et al. Systemic contact dermatitis due to fusidic acid. Contact Dermatitis 2006 Mar; 54 (3): 169

  30. Corazza M, Mantovani L, Montanari A, et al. Allergic contact dermatitis from transdermal estradiol and systemic contact dermatitis from oral estradiol: a case report. J Reprod Med 2002 Jun; 47 (6): 507–9

    Google Scholar 

  31. Gallo R, Parodi A. Baboon syndrome from 5-aminosalicylic acid. Contact Dermatitis 2002 Feb; 46 (2): 110

  32. Tamagawa-Mineoka R, Katoh N, Yoneda K, et al. Systemic allergic contact dermatitis due to phenylephrine in eyedrops, with a long-lasting allergic patch test reaction. Eur J Dermatol 2010 Jan-Feb; 20 (1): 125–6

    Google Scholar 

  33. Sasseville D. Clinical patterns of pytodermatitis. Dermatol Clin 2009 Jul; 27 (3): 299–308

  34. Rodríguez-Serna M, Sanchez-Motilla JM, Ramon R, et al. Allergic and systemic contact dermatitis from Matricaria chamomilla tea. Contact Dermatitis 1998 Oct; 39 (4): 192–3

    Google Scholar 

  35. Mahajan VK, Sharma NL, Sharma RC. Parthenium dermatitis: is it a systemic contact dermatitis or an airborne contact dermatitis? Contact Dermatitis 2004 Nov-Dec; 51 (5-6): 231–4

  36. Oh SH, Haw CR, Lee MH. Clinical and immunologic features of systemic contact dermatitis from ingestion of Rhus (Toxicodendron). Contact Dermatitis 2003 May; 48 (5): 251–4

    Google Scholar 

  37. Cardinali C, Francalanci S, Giomi B, et al. Systemic contact dermatitis from herbal and homeopathic preparations used for herpes virus treatment. Acta Derm Venereol 2004; 84 (3): 223–6

    Article  PubMed  Google Scholar 

  38. Park SD, Lee SW, Chun JH, et al. Clinical features of 31 patients with systemic contact dermatitis due to the ingestion of Rhus (lacquer). Br JDermatol 2000 May; 142 (5): 937–42

    Google Scholar 

  39. Pfutzner W, Thomas P, Niedermeier A, et al. Systemic contact dermatitis elicited by oral intake of Balsam of Peru. Acta Derm Venereol 2003; 83 (4): 294–5

    Article  PubMed  Google Scholar 

  40. Pfutzner W, Niedermeier A, Thomas P, et al. Systemic contact eczema against Balsam of Peru. J Dtsch Dermatol Ges 2003 Sep; 1 (9): 719–21

    Google Scholar 

  41. Pereira F, Hatia M, Cardoso J. Systemic contact dermatitis from diallyl disulfide. Contact Dermatitis 2002 Feb; 46 (2): 124

  42. Lowther A, McCormick T, Nedorost S. Systemic contact dermatitis from propylene glycol. Dermatitis 2008 Mar-Apr; 19 (2): 105–8

  43. Hill AM, Belsito DV. Systemic contact dermatitis of the eyelids caused by formaldehyde derived from aspartame? Contact Dermatitis 2003 Nov; 49 (5): 258–9

  44. Watanabe T, Yoshida Y, Yamamoto O. Enteral nutrition induced systemic allergic dermatitis. Contact Dermatitis 2008 Dec; 59 (6): 374–5

  45. Menne T, Weismann K. Hematogenous contact eczema following oral administration of neomycin. Hautarzt 1984; 35: 319–20

    PubMed  CAS  Google Scholar 

  46. Guin JD, Fields P, Thomas KL. Baboon syndrome from i.v. aminophylline in a patient allergic to ethylendiamine. Contact Dermatitis 1999; 40: 170–1

    Article  PubMed  CAS  Google Scholar 

  47. Isaksson M, Ljunggren B. Systemic contact dermatitis from ethylendiamine in an aminophylline preparation presenting as the baboon syndrome. Acta Derm Venereol 2003; 83: 69–70

    Article  PubMed  CAS  Google Scholar 

  48. Proske S, Uter W, Schnuch A, et al. Severe allergic contact dermatitis with generalized spread due to bufexamac presenting as the ‘baboon’ syndrome. Dtsch Med Wochenschr 2003; 128: 545–7

    Article  PubMed  CAS  Google Scholar 

  49. Marques C, Faria E, Machado A, et al. Allergic contact dermatitis and systemic contact dermatitis from cinchocaine. Contact Dermatitis 1995; 33: 443

    Article  PubMed  CAS  Google Scholar 

  50. Erdmann SM, Sachs B, Merk HF. Systemic contact dermatitis from cinchocaine. Contact Dermatitis 2001; 44: 260–1

    PubMed  CAS  Google Scholar 

  51. Montag G, Weber L, Gall H. Baboon-syndrom auf Allopurinol. Akt Dermatol 1996; 22: 311–3

    Google Scholar 

  52. Wolf R, Brenner S, Krakowski A. Intertriginous drug eruption. Acta Derm Venereol 1992; 72: 441–2

    PubMed  CAS  Google Scholar 

  53. Wolf R, Orion E, Matz H. The baboon syndrome or intertriginous drug eruption: a report of eleven cases and a second look at its pathomechanism. Dermatol Online J 2003; 9: 2

    PubMed  Google Scholar 

  54. Herfs H, Schirren CG, Przybilla B, et al. Baboon syndrome: a particular manifestation of hematogenous contact reaction. Hautarzt 1993; 44: 466–9

    PubMed  CAS  Google Scholar 

  55. Duve S, Worret W, Hofmann H. The baboon syndrome: a manifestation of hematogenous contact-type dermatitis. Acta Derm Venereol 1994; 76: 480–1

    Google Scholar 

  56. Kohler LD, Schonlein K, Kautzky F, et al. Diagnosis at first glance: the baboon syndrome. Int J Dermatol 1996; 35: 502–3

    Article  PubMed  CAS  Google Scholar 

  57. Wakelin SH, Sidhu S, Orton DI, et al. Amoxycillin-induced flexural exanthem. Clin Exp Dermatol 1999; 24: 71–3

    Article  PubMed  CAS  Google Scholar 

  58. Kick G, Przybilla B. Delayed prick test reaction identifies amoxicillin as elicitating baboon syndrome. Contact Dermatitis 2000; 43: 366–7

    PubMed  CAS  Google Scholar 

  59. Loze I, Milpied-Homsi B, Parent E, et al. Le syndrome babouin, une toxidermie particuliere: quatre observations. Nouv Dermatol 2001; 20: 624–5

    Google Scholar 

  60. Strub C, Bircher AJ. Exanthemwith emphasis of body flexure points 10 hours after administration of amoxicillin ‘baboon syndrome’. Schweiz Rundsch Med Prax 2002; 91: 232–4

    CAS  Google Scholar 

  61. Schultz ES, Diepgen TL. Clinical characteristics and the causes of the baboon syndrome. Dermatosen 1996; 44: 266–9

    Google Scholar 

  62. Rasmussen LP, Menne T. Systemic contact eczema in ampicillin allergy. Ugeskr Laeger 1995; 147: 1341–2

    Google Scholar 

  63. Helmbold P, Hegemann B, Dickert C, et al. Symmetric psychotropic and nonpigmenting fixed drug eruption due to cimetidine (so-called baboon syndrome). Dermatology 1998; 197: 402–3

    Article  PubMed  CAS  Google Scholar 

  64. Wolf R, Elman M, Brenner S. Drug-induced ‘intertrigo’. Int J Dermatol 1993; 32: 515–6

    Article  PubMed  CAS  Google Scholar 

  65. Garcia-Bravo B, Repiso JB, Camacho F. Systemic contact dermatitis due to deflazacort. Contact Dermatitis 2000; 43: 359–60

    Article  PubMed  CAS  Google Scholar 

  66. Goossens C, Sass U, Song M. Baboon syndrome. Dermatology 1997; 194: 421–2

    Article  PubMed  CAS  Google Scholar 

  67. Pfeiff B, Pullmann H. Baboon-artiges arzneiexanthem auf heparin. Deutsch Dermatologe 1991; 39: 559–60

    Google Scholar 

  68. Chowdhury MM, Patel GK, Inaloz HS, et al. Hydroxyurea-induced skin disease mimicking the baboon syndrome. Clin Exp Dermatol 1999; 24: 336–7

    Article  PubMed  CAS  Google Scholar 

  69. Barbaud A, Trechot P, Granel F, et al. A baboon syndrome induced by intravenous human immunoglobulins: report of a case and immunological analysis. Dermatology 1999; 199: 258–60

    Article  PubMed  CAS  Google Scholar 

  70. De Groot AC, Conemans JM. Systemic allergic contact dermatitis from intravesical instillation of the antitumor antibiotic mitomycin C. Contact Dermatitis 1991; 24: 201–9

    Article  PubMed  Google Scholar 

  71. Lechner T, Grytzmann B, Baurle G. Hematogenous allergic contact dermatitis after oral administration of nystatin. Mykosen 1987; 30: 143–6

    PubMed  CAS  Google Scholar 

  72. Panhans-Gross A, Gall H, Peter RU. Baboon syndrome after oral penicillin. Contact Dermatitis 1999; 41: 352–3

    Article  PubMed  CAS  Google Scholar 

  73. Sanchez TS, Sanchez-Perez J, Aragues M, et al. Flare-up reaction of pseudoephedrine baboon syndrome positive patch test. Contact Dermatitis 2000; 42: 312–3

    PubMed  CAS  Google Scholar 

  74. Sanchez-Morillas L, Reano Martos M, Rodriguez Mosquera M, et al. Baboon syndrome due to pseudoephedrine. Contact Dermatitis 2003; 48: 234

    Article  PubMed  CAS  Google Scholar 

  75. Amichai B, Grunwald MH. Baboon syndrome following oral roxithromycin. Clin Exp Dermatol 2002; 27: 523

    PubMed  CAS  Google Scholar 

  76. Gordon E. Baboon syndrome caused by Salasate. J Drugs Dermatol 2002; 1: 66

    PubMed  Google Scholar 

  77. Weiss JM, Mockenhaupt M, Schopf E, et al. Reproducible drug exanthema to terbinafine with characteristic distribution of baboon syndrome. Hautarzt 2001; 52: 1104–6

    Article  PubMed  CAS  Google Scholar 

  78. Monzon S, Del Mar Garces M, Lezaun A, et al. Ambroxol-induced systemic contact dermatitis confirmed by positive patch test. Allergol Immunopathol 2009 May-Jun; 37 (3): 167–8

  79. Elmariah SB, Cheung W, Wang N, et al. Systemic drug-related intertriginous and flexural exanthema (SDRIFE). Dermatol Online J 2009 Aug 15; 15 (8): 3

  80. Sans V, Jouary T, Hubiche T, et al. Baboon syndrome induced by cetuximab. Arch Dermatol 2008 Feb; 144 (2): 272–4

  81. Watanabe T, Yamada N, Yoshida Y, et al. A case of symmetrical drug-related intertriginous and flexural exanthema induced by loflazepate ethyl. J Eur Acad Dermatol Venereol 2010 Mar; 24 (3): 357–8

  82. Ferreira A, Mota A, Morais P, et al. Symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) induced by telmisartan-hydrochlorothiazide. Cutan Ocul Toxicol 2010 Dec; 29 (4): 293–5

    Google Scholar 

  83. Arnold AW, Hausermann P, Bach S, et al. Recurrent flexural exanthema (SDRIFE or baboon syndrome) after administration of two different iodinated radio contrast media. Dermatology 2007; 214 (1): 89–93

    Article  PubMed  CAS  Google Scholar 

  84. Handisurya A, Stingl G, Wöhrl S. SDRIFE (baboon syndrome) induced by penicillin. Clin Exp Dermatol 2009 Apr; 34 (3): 355–7

  85. Waltermann K, Geier J, Diessenbacher P, et al. Systemic allergic contact dermatitis from intravenous piritramide. Allergy 2010 Sep; 65 (9): 1203–4

  86. Akay BN, Sanli H. Symmetrical drug-related intertriginous and flexural exanthem due to oral risperidone. Pediatr Dermatol 2009 Mar-Apr; 26 (2): 214–6

  87. Allain-Veyrac GG, Lebreton A, Collonnier C, et al. First case of symmetric drug-related intertriginous and flexural exanthema (SDRIFE) due to rivastigmine? Am J Clin Dermatol 2011; 12 (3): 210–3

    Article  PubMed  Google Scholar 

  88. Daito J, Hanada K, Katoh N, et al. Symmetrical drug-related intertriginous and flexural exanthemacaused by valacyclovir. Dermatology 2009; 218 (1): 60–2

    Article  PubMed  Google Scholar 

  89. Cunha D, Carvalho R, Santos R, et al. Systemic allergic dermatitis to epsilonaminocaproic acid. Contact Dermatitis 2009 Nov; 61 (5): 303–4

  90. Thyssen JP, Maibach HI. Drug-elicited systemic allergic (contact) dermatitis: update and possible pathomechanism. Contact Dermatitis 2008; 59: 195–202

    Article  PubMed  CAS  Google Scholar 

  91. Wolf R, Barzilai A, Davidovici B. Intertriginous lymphomatoid drug eruption. Int J Dermatol 2010 Oct; 49 (10): 1207–9

    Google Scholar 

  92. Guevara-Gutierrez E, Uribe-Jimenez E, Diaz-Canchola M, et al. Acute generalized exanthematous pustulosis: report of 12 cases and literature review. Int J Dermatol 2009 Mar; 48 (3): 253–8

    Google Scholar 

  93. Roujeau JC, Bioulac-Sage P, Bourseau C, et al. Acute generalized exanthematous pustulosis: analysis of 63 cases. Arch Dermatol 1991 Sep; 127 (9): 1333–8

  94. Webber KA, Kos L, Holland KE, et al. Intertriginous eruption associated with chemotherapy in pediatric patients. Arch Dermatol 2007 Jan; 143 (1): 67–71

  95. Valks R, Fraga J, Porras-Luque J, et al. Chemotherapy-induced eccrine squamous syringometaplasia: a distinctive eruption in patients receiving hematopoietic progenitor cells. Arch Dermatol 1997 Jul; 133 (7): 873–8

    Google Scholar 

  96. Hurt MA, Halvorson RD, Petr Jr FC, et al. Eccrine squamous syringometaplasia: a cutaneous sweat gland reaction in the histologic spectrum of ‘chemotherapy-associated eccrine hidradenitis’ and ‘neutrophilic eccrine hidradenitis’. Arch Dermatol 1990 Jan; 126 (1): 73–7

  97. Honig PJ, Frieden IJ, Kim HJ, et al. Streptococcal intertrigo: an underrecognized condition in children. Pediatrics 2003 Dec; 112 (6 Pt 1): 1427–9

    Google Scholar 

  98. Iwatsuki K, Yamasaki O, Morizane S, et al. Staphylococcal cutaneous infections: invasion, evasion and aggression. J Dermatol Sci 2006 Jun; 42 (3): 203–14

  99. Janniger CK, Schwartz RA, Szepietowski JC, et al. Intertrigo and common secondary skin infections. Am Fam Physician 2005 Sep 1; 72 (5): 833–8

  100. Meier M, Sheth PB. Clinical spectrum and severity of psoriasis. Curr Probl Dermatol 2009; 38: 1–20

    Article  PubMed  Google Scholar 

  101. Szigeti R, Kellermayer R. Autosomal-dominant calcium AT Pase disorders. J Invest Dermatol 2006 Nov; 126 (11): 2370–6

  102. Madan V, August PJ. Exophytic plaques, blisters,and mouth ulcers: pemphigus vegetans (PV), Neumann type. Arch Dermatol 2009 Jun; 145 (6): 715–20

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, Sunnybrook Hospital, University of Toronto, Toronto, Ontario, Canada

    Monika Winnicki & Neil H. Shear

  2. Sunnybrook Dermatology Clinic, 2075 Bayview Avenue, Suite M1-700, Toronto, Ontario, Canada, M4N 3M5

    Monika Winnicki

Authors
  1. Monika Winnicki
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Neil H. Shear
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Monika Winnicki.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Winnicki, M., Shear, N.H. A Systematic Approach to Systemic Contact Dermatitis and Symmetric Drug-Related Intertriginous and Flexural Exanthema (SDRIFE). Am J Clin Dermatol 12, 171–180 (2011). https://doi.org/10.2165/11539080-000000000-00000

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/11539080-000000000-00000

Keywords

Search

Navigation